1 |
Nguyen T, Deangelis LM. Treatment of bain metastases. J Support Oncol 2004;2:405-410 discussion 411-416.
|
2 |
Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 2011;11:352-363.
DOI
ScienceOn
|
3 |
Soffietti R, RudàR, Trevisan E. Brain metastases: current management and new developments. Curr Opin Oncol 2008;20:676-684.
DOI
ScienceOn
|
4 |
Kienast Y, Winkler F. Therapy and prophylaxis of brain metastases. Expert Rev Anticancer Ther 2010:10:1763-1777.
DOI
ScienceOn
|
5 |
Lagerwaard FL, Levendag PJ, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795-803.
DOI
ScienceOn
|
6 |
Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751.
DOI
ScienceOn
|
7 |
Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-514.
DOI
ScienceOn
|
8 |
Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
DOI
ScienceOn
|
9 |
Franzini A, Leocata F, Giorgi C, Allegranza A, Servello D, Broggi G. Role of stereotactic biopsy in multifocal brain lesions: considerations on 100 consecutive cases. J Neurol Neurosurg Psychiatry 1994;57:957-960.
DOI
ScienceOn
|
10 |
Engenhart R, Kimmig BN, Hover KH, et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradia Cancer 1993;71:1353-1361.
DOI
ScienceOn
|
11 |
Auchter RM, Lamond JP, Alexander E, et al. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain meis. Int J Radiat Oncol Biol Phys 1996;35:27-35.
DOI
ScienceOn
|
12 |
Carman TL, Kanner AA, Barnett GH, Deitcher SR. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J 2003;96:17-22.
DOI
ScienceOn
|
13 |
Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-590.
DOI
ScienceOn
|
14 |
Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489.
DOI
ScienceOn
|
15 |
Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol 2010;22:627-635.
DOI
ScienceOn
|
16 |
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology [Internet].:Central Nervous System Cancers, v.2.2011. [cited 2011 Aug 8]. Available from:http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
|
17 |
Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningealdissemination of metastatic tumors. Lancet Oncol 2010;11:871-879.
DOI
ScienceOn
|
18 |
Shiue K, Sahgal A, Chow E, et al. Management of metastatic spinal cord compression. Expert Rev Anticancer Ther 2010;10:697-708. Erratum in: Expert Rev Anticancer Ther 2010;10:1162.
DOI
ScienceOn
|
19 |
Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O.High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-144.
|
20 |
Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH.Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomized trial. Eur J Cancer 1994;30A:22-27.
|
21 |
Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-1257 .
DOI
|
22 |
Klimo P Jr, Kestle JR, Schmidt MH. Treatment of metastatic spinal epidural disease: a review of the literature. Neurosurg Focus 2003;15:E1.
|
23 |
Chamberlain MC, Kormanik PA. Epidural spinal cord compression: a single institution's retrospective experience. Neuro Oncol 1999;1:120-123.
|
24 |
Rades D, Stalpers LJ, Hulshof MC, Zschenker O, Alberti W, Koning CC. Effectiveness and toxicity of single-fraction radio-therapy with 1 8 Gy for metastatic spinal cord compression. Radiother Oncol 2005;75:70-73.
DOI
ScienceOn
|
25 |
van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-328.
DOI
ScienceOn
|
26 |
Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375.
DOI
ScienceOn
|
27 |
Rades D, Stalpers LJ, Hulshof MC, et al. Comparison of 1 8 Gy and 10 3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2005;62:514-518.
DOI
ScienceOn
|
28 |
Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine (Phila Pa 1976) 2001;26:818-824.
DOI
ScienceOn
|
29 |
Rades D, Lange M, Veninga T, et al. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2009;73:228-234.
DOI
ScienceOn
|
30 |
Williams BJ, Fox BD, Sciubba DM, et al. Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine 2009;10:414-422.
DOI
ScienceOn
|
31 |
Healey JH, Brown HK. Complications of bone metastases: surgical management. Cancer 2000;88(12 Suppl):S2940-S2951.
|
32 |
Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004;9:188-196.
DOI
ScienceOn
|